http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018351533-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b92a939ea3ce54629de74298268fba3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f66670ca35a646dd3ed3f0d0c96f07a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc4e8aaf010bb2ad935e6419549ad2b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7d8b5a6b1f36f110a2099b874e206c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de29834d736850580e4b0c17a041a55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa7ff3479c3cfe3958b7254679d36211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d7b811e5667f3e94c98c663834b9988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ba1a2c4a1c74b64f29f9a868f56133e
publicationDate 2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2018351533-A1
titleOfInvention Crystalline forms and compositions of CFTR modulators
abstract Crystalline Forms of Compound (I): (Formula (I)) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
priorityDate 2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433140321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465387730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429973923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59830733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467241531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429972027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414699786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415901803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134398740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122456163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134393460

Total number of triples: 38.